Lung cancer. Developments, concepts and preview of the new WHO classification

被引:0
|
作者
Petersen, I. [1 ]
Warth, A. [2 ]
机构
[1] Univ Klinikum Jena, Inst Pathol, D-07743 Jena, Germany
[2] Univ Klinikum Heidelberg, Inst Pathol, Heidelberg, Germany
来源
PATHOLOGE | 2014年 / 35卷 / 06期
关键词
Pulmonary neoplasms; Diagnosis; Classification; Immunohistochemistry; Molecular pathology; RESPIRATORY SOCIETY CLASSIFICATION; GIANT-CELL CARCINOMA; INTERNATIONAL ASSOCIATION; IASLC/ATS/ERS CLASSIFICATION; PULMONARY ADENOCARCINOMAS; RHABDOID PHENOTYPE; INTEROBSERVER; MUTATIONS; PROGNOSIS; DIAGNOSIS;
D O I
10.1007/s00292-014-1915-1
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The diagnostics of pulmonary neoplasms has considerably changed in recent years. Based on large-scale molecular characterization studies and the development of targeted therapies, precise morphological, immunohistochemical and molecular pathological tumor subtyping is now of utmost importance for evidence-based treatment decisions. This review highlights recent developments in morphological and immunohistochemical subtyping of pulmonary neoplasms, concepts of tumor progression and provides a preview of relevant changes of the forthcoming new WHO classification, which is expected to be published in 2015. It becomes apparent that a 3-step diagnostic procedure based on morphology, immunohistochemistry and molecular pathology is important to meet the requirements of an increasingly more complex, interdisciplinary care of lung cancer patients and to allow reliable, clinically meaningful tumor diagnosis.
引用
收藏
页码:547 / 556
页数:10
相关论文
共 50 条
  • [1] Lung cancer: developments, concepts, and specific aspects of the new WHO classification
    Petersen, Iver
    Warth, Arne
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (05) : 895 - 904
  • [2] Lung cancer: developments, concepts, and specific aspects of the new WHO classification
    Iver Petersen
    Arne Warth
    [J]. Journal of Cancer Research and Clinical Oncology, 2016, 142 : 895 - 904
  • [3] Oligometastatic lung cancer. New concepts of prognostic relevance
    Sterzing, F.
    Eberhardt, W.
    Friedel, G.
    Poettgen, C.
    Rieken, S.
    [J]. ONKOLOGE, 2014, 20 (10): : 991 - 997
  • [4] New developments in the treatment of esophageal cancer.
    Ilson D.H.
    [J]. Current Oncology Reports, 2002, 4 (3) : 213 - 221
  • [5] Karzinome der LungeEntwicklungen, Konzepte und Ausblick auf die neue WHO-KlassifikationLung cancerDevelopments, concepts and preview of the new WHO classification
    I. Petersen
    A. Warth
    [J]. Der Pathologe, 2014, 35 (6): : 547 - 556
  • [6] Recent developments in weekly paclitaxel therapy in lung cancer.
    Akerley W.
    [J]. Current Oncology Reports, 2001, 3 (2) : 165 - 169
  • [7] New in 2019: a preview of the improved bedrock of cancer classification
    Nagtegaal, I. D.
    [J]. COLORECTAL DISEASE, 2019, 21 (01) : 5 - 5
  • [8] The New WHO Classification of Lung Tumors
    Tsao, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S63 - S63
  • [9] New concepts on hormone dependence in breast cancer.
    Levin, E
    Caruso, SP
    Actis, AM
    DeLevin, RW
    [J]. MEDICINA-BUENOS AIRES, 1997, 57 (01) : 95 - 103
  • [10] Breast cancer: new concepts in classification
    Couto Vieira, Daniella Serafin
    Dufloth, Rozany Mucha
    Lander Schmitt, Fernando Carlos
    Zeferino, Luiz Carlos
    [J]. REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2008, 30 (01): : 42 - 47